Get started
Author

Matthieu Delaye

Observed names: Delaye, Matthieu, M. Delaye, Matthieu Delaye, MD
Observed institutions: Centre National de la Recherche Scientifique, Université de Versailles Saint-Quentin-en-Yvelines, Université Paris Sciences et Lettres, Université Paris-Saclay, Institut Gustave Roussy, École Normale Supérieure - PSL, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Antoine, Hôpital René Huguenin, Hospital Agioi Anargyroi, GERCOR (France), Hôpital Raymond-Poincaré, Biologie cellulaire et Cancer, Hôpital Tenon, Fondation Gustave Roussy, Institut Curie
ORCID: 0000-0002-2435-4757
Observed ORCID: 0000-0002-2435-4757
OpenAlex ID: A5090932631
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial
2024 · T. Conroy, F. Castan, et al. · Annals of Oncology · 284
PDF
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: 7-year results of PRODIGE 23 phase III trial, a UNICANCER GI trial.
2023 · Thierry Conroy, Pierre-Luc Etienne, et al. · Journal of Clinical Oncology · 108
The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapy
2023 · Marc Hilmi, Matthieu Delaye, et al. · The Lancet. Gastroenterology & hepatology · 81
PDF
Biomarkers in Hepatobiliary Cancers: What Is Useful in Clinical Practice?
2021 · Alice Boilève, Marc Hilmi, et al. · Cancers · 30
PDF
Obesity, cancer, and response to immune checkpoint inhibitors: Could the gut microbiota be the mechanistic link?
2023 · Matthieu Delaye, Adrien Rousseau, et al. · Pharmacology & Therapeutics · 19
PDF
Prognostic Value of Fusobacterium nucleatum after Abdominoperineal Resection for Anal Squamous Cell Carcinoma
2022 · Marc Hilmi, Cindy Neuzillet, et al. · Cancers · 17
PDF
KRAS, a New Target for Precision Medicine in Colorectal Cancer?
2024 · Alice Boilève, Cristina Smolenschi, et al. · Cancers · 16
PDF
Integrating Environmental Impact in Health Technology Assessment: An Exploratory Study
2025 · Coline Ducrot, Julien Péron, et al. · PharmacoEconomics · 12
PDF
High-dose chemotherapy with autologous stem cell transplants in adult primary non-seminoma mediastinal germ-cell tumors. A report from the Cellular Therapy and Immunobiology working party of the EBMT
2024 · S. Secondino, M. Badoglio, et al. · ESMO Open · 12
Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection
2023 · Abderaouf Hamza, Julien Masliah‐Planchon, et al. · International Journal of Cancer · 12
PDF
Objectifs, motivations et difficultés des internes en phase socle en oncologie
2021 · Marc Hilmi, Elisabeth Ashton, et al. · Bulletin du Cancer · 12
PDF
Durvalumab (D) plus tremelimumab (T) immunotherapy in patients (Pts) with advanced biliary tract carcinoma (BTC) after failure of platinum-based chemotherapy (CTx): Interim results of the IMMUNOBIL GERCOR D18-1 PRODIGE-57 study.
2022 · Matthieu Delaye, Eric Assenat, et al. · Journal of Clinical Oncology · 10
First-line chemotherapy with selective internal radiation therapy for intrahepatic cholangiocarcinoma: The French ACABi GERCOR PRONOBIL cohort
2024 · Nicolas Adamus, Julien Edeline, et al. · JHEP Reports · 9
PDF
Inclusion of patients with chronic kidney disease in randomized phase 3 clinical trials in patients with prostate, breast, lung, and colorectal cancer
2022 · Matthieu Delaye, Adrien Rousseau, et al. · Cancer Medicine · 9
Rational testing for gene fusion in colorectal cancer: MSI and RAS-BRAF wild-type metastatic colorectal cancer as target population for systematic screening
2022 · Matthieu Delaye, Sabrina Ibadioune, et al. · European Journal of Cancer · 9
PDF
Toward Precision Chemotherapy for Pancreatic Cancer Guided by Transcriptomic Signatures
2025 · Brice Chanez, Matthieu Delaye, et al. · United European Gastroenterology Journal · 7
PDF
Real-life data on biliary tract cancers in France: The nested Amber study from the French ACABi GERCOR PRONOBIL retro-prospective, observational cohort
2024 · Matthieu Delaye, Alice Boilève, et al. · Digestive and Liver Disease · 7
PDF
Imagerie des cancers et prévention de l’insuffisance rénale
2022 · Sylvain Bodard, Dris Kharroubi-Lakouas, et al. · Bulletin du Cancer · 6
PDF
AMM : entrectinib et larotrectinib – cancers avec fusion NTRK
2020 · Matthieu Delaye, Manuel Rodrigues · Bulletin du Cancer · 6
PDF
Young-onset biliary tract cancers: Characteristics, treatment patterns, and patient outcomes
2025 · Thomas Pudlarz, Anthony Turpin, et al. · JHEP Reports · 5
PDF
Management of Pain Medication in Patients With a History of Bariatric Surgery: A Systematic Review
2024 · Matthieu Delaye, Arthur Geraud, et al. · Journal of Pain and Symptom Management · 5
PDF
Medical oncologist stereotypes among medical students, residents and physicians: a national cross-sectional study
2023 · Max Piffoux, Matthieu Delaye, et al. · BMJ Supportive & Palliative Care · 5
État des lieux des pratiques de prise en charge des cancers des voies biliaires en France : résultats de l'enquête nationale ACABi
2022 · Matthieu Delaye, Eric Assenat, et al. · Bulletin du Cancer · 5
État des lieux de la formation initiale de l’internat d’oncologie après la quatrième vague pandémie de la COVID-19 : une enquête AERIO-SFJRO
2022 · Adrien Rousseau, Quentin Laune, et al. · Bulletin du Cancer · 5
PDF
SARS-CoV-2 et cancer en France : les internes d’oncologie en première ligne. Témoignage des internes d’oncologie de deux clusters français : le Grand-Est et l’Île-de-France
2020 · Matthieu Delaye, Natacha Naoun, et al. · Bulletin du Cancer · 5
PDF
Works count: 113
Citation count: 753
H-index: 11
I10-index: 12
Year
Topic
Type